Abstract: Alcohol based aerosol spray compositions which contain 1-20% of an alcohol-soluble polymer which, on evaporation, leaves on a sprayed surface a film which acts as a barrier to dust, dust mites and their faecal excretions. These compositions optionally can include an acaricidal ingredient, such as benzyl benzoate, and one or more antimicrobial ingredients such as a quaternary ammonium salt.

Abstract: An artificial surface active soft plastic lure (16) includes emulsifiers so that the plastic lure (16) reacts in the presence of water and loses a measurable portion of its mass. Fish attractants and stimulants (12) are added to the surface active soft plastic lure (16) so that as the lure (16) reacts, fish attractants and stimulants (12) are actually released into the water for sensing by fish. The emulsifiers are selected from a group of chemicals including nonionic, amphoteric, alkanolamide, sorbitan monooleates, fatty acids, sulfonates, fatty esters, phosphate esters, amines, anionic, cationic, monostearates, sorbitan tristearates, and sorbitan trioleates. Preferred fish attractants include dehydrated protein and amino acids, in particular amino acids which are water soluble and alkaline or neutral substances having a pH of approximately 7-8. In the preferred embodiments, the amino acids are selected from a group including betaine, glycine, glutamic acid, proline, taurine and valine.

Abstract: A microencapsulation method of a biologically active solid substance that is characterized by polymerizing a monomer that is polymerizable by condensation in a dispersion containing i) a solution containing a nonionic substance and ii) the biologically active solid substance that is insoluble or difficult to dissolve in said solution, wherein the nonionic substance is effective for dispersing the biologically active substance in said solution, is an effective method for producing a microencapsulated composition without aggregation.

Abstract: The medicament of the present invention and its process of manufacturing employs a caplet or tablet core with a clear or single color uniform covering which can be applied either through an enrobing process, by spraying or by a single dip-coating step. The core itself can have a first color or be colorless, and its clear or single color covering has the outer surface of one end or one side colored by a suitable dye to provide a two-color appearance. The dye can be applied by dipping or spray painting with a suitable jet-spraying apparatus. In a preferred embodiment, the covering is of a clear gelatinous material.

Abstract: The present invention is directed to a cosmetic composition comprising at least one neutralized ionic film-forming polymer, water and least one polar organic solvent which is at least partially water-miscible and of higher boiling point than the boiling point of water, wherein the film-forming polymer is insoluble in water and is soluble in the organic solvent when it is in a non-neutralized state. In addition the neutralized film-forming polymer is soluble in the mixture of organic solvent and water and further wherein the mixture of neutralized polymer, organic solvent and water is a single phase, where the single phase is a homogeneous solution.

Abstract: The invention provides a composition whitening teeth, using a bleaching compound and a catalytic activator, where the catalytic activator catalyzes the reaction of a significant portion of the bleaching compound within in a short period of time. A method for whitening teeth by providing a bleaching compound, providing a catalytic agent, and combining the bleaching agent with the catalytic agent so that a reaction of a significant portion of the bleaching agent occurs in a short period of time is also disclosed. A device for whitening teeth, consisting of a toothbrush where at least one of the bristles contains a catalytic activator is also provided. The handle of this device has a reservoir for a bleaching compound and a means for dispensing the bleaching compound. Another device for whitening teeth, consisting of a toothbrush with a catalytic activator capable of catalyzing the reaction of a bleaching compound applied to the head of the device, is further provided.

Abstract: Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24 hours, have a dissolution rate in-vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer at 37.degree. C. from about 12.5% to about 42.5% (by weight) active agent released after 1 hour, from about 25% to about 55% (by weight) active agent released after 2 hours, from about 45% to about 75% (by weight) opioid analgesic released after 4 hours and greater than about 60% (by weight) opioid analgesic released after a hours, the in-vitro release rate being substantially independent of pH and chosen such that the peak plasma level of active agent obtained in-vivo between about 2 and about 8 hours after administration of the dosage form.

Abstract: Use of calcium taurate as an antihypertensive agent and dietary supplement. The compound is prepared by reacting taurine and calcium in a 2:1 molar ratio. The resulting mixture is diluted with alcohol and the remaining clear filtrate is crystallized. Calcium taurate is taken orally as nutritional supplement or antihypertensive agent, and can be used as an adjuvant to conventional antihypertensive drugs.

Abstract: The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by exposure to aqueous streams. The present invention also provides a simple and reliable method for controlled dispensing of such tableted formulations into a liquid stream that is particularly advantageous for use in micro-gravity environments, such as spacecraft urinal systems.

Abstract: A method of inhibiting hair growth in a mammal includes applying, to an area of skin from which reduced hair growth is desired, a dermatologically acceptable composition containing a non-steroidal suppressor of angiogenesis.

Abstract: Aqueous dispersions of 2-(4-thiazolyl)-benzimidazole (TBZ), alone or in combination with 1,2-dibromo-2,4-dicyanobutane (DBDCB), and processes for making the same, are disclosed. These processes generally comprise mixing a xanthan gum with water, adding TBZ and mixing until uniform. DBDCB dispersions are prepared by mixing xanthan gum with water, adding DBDCB, maintaining the mixture at a temperature below about 40.degree. C., grinding the mixture and mixing until uniform. The TBZ and DBDCB dispersions are then blended to prepare a dispersion containing both active ingredients. A method for inhibiting microbial growth utilizing these dispersions is also claimed.

Abstract: Process for the preparation of oil-in-water creams comprising the steps ofI forming a low-viscosity, very fine particle oil-in-water emulsion by heating the following composition to a temperature within or above its phase inversion temperature range:A) 1 part by weight of liquid oil component,B) from about 0.1 to about 0.5 parts by weight of at least one nonionic emulsifier having an HLB value of from 11 to 15,C) from about 0.1 to about 0.2 parts by weight of at least one co-emulsifier selected from saturated fatty alcohols containing 16 to 22 carbon atoms and partial esters of polyols containing 3 to 6 carbon atoms with saturated fatty acids containing 143 to 22 carbon atoms, andD) from about 1 to about 6 parts by weight of water; andII thickening the emulsion from step I to the consistency of a cream by adding thereto at least one consistency generator selected from co-emulsifiers defined in step I C) above and water-soluble polymers, wherein the thickened emulsion exhibits plastic behavior at 20.degree. C.

Abstract: A method and composition for reducing adenosine levels comprises administering a dehydroepiandrosterone, and optionally a ubiquinone.

Abstract: A method of reducing the incidence of splenomegalia induced by ultra violet radiation in mammals by exposing a group of test mammals to intense ultraviolet radiation, where the exposure is repeated at regular intervals over a test period such that the cumulative radiation exposure per mammal is sufficient to cause an increase in an average spleen size in a group of unprotected mammals; and administering drinking water containing a defined concentration of betanins to the group of test mammals during the test period, said defined concentration being sufficient to prevent such an increase in average spleen size.

Abstract: An oral dosage form of morphine is formulated by powder-layering an homogeneous mixture of morphine sulfate and hydrous lactose impalpable onto inert beads to obtain a multiparticulate product. A plurality of the powder-layered beads may be administered either in immediate release form or in an extended release form by coating with a hydrophobic material. In addition, multi-particulate oral dosage forms containing therapeutically effective agents containing a plurality of pharmaceutically acceptable inert beads powder-layered with homogeneous mixture of a therapeutically effective agent and hydrous lactose impalpable are also disclosed. A method of preparing the dosage forms as well as a method preparing spheroids containing the homogeneous mixture of therapeutically effective agent and hydrous lactose impalpable are also disclosed.

Abstract: Disclosed is a method for delivering an active protein or peptide to the colon. The steps of the method include providing a multiparticulate dosage core particle comprising 3 components, the total weight of the 3 components in dry form defining a batch size. The multiparticulate core particle is produced by the method comprising: a) providing an aqueous PEG solution, the dry weight of the PEG component representing from about 2.5% to about 15% of the batch size (weight/weight), the water component of the aqueous PEG solution representing approximately 30-60% of the batch size (weight/weight); b) providing a homogenous mixture of the active protein or peptide and microcrystalline cellulose, both in dry form, the active protein or peptide comprising from about 50% to about 95% of the batch size (weight/weight) and the microcrystalline cellulose comprising from about 2.

Abstract: According to the present invent, effervescent granules having a controllable rate of effervescence are provided. Such granules comprise an acidic agent, an alkaline agent, a hot-melt extrudable binder capable of forming a eutectic mixture with the acidic agent and, optionally, a plasticizer. The effervescent granules are made by a hot-melt extrusion process.

Abstract: A delivery mechanism and device for the passive periodic release of a drug or an active ingredient which avoids the need for external power sources and/or electronic controllers. By taking advantage of oscillating chemical systems, one can change the state, i.e. the pH, of a solution, a drug, enhancer or solubilizer resulting in oscillating the ability of an active ingredient to be delivered transdermally. The pH of a solution can be oscillated over a range of pH values from 2 to 10 by the reduction and oxidation (redox) reactions of salts, such as permanganates, iodates, sulfates, chlorates, or bromates. Upon activation, the delivery system conditions begin to oscillate and with it, the delivery of the active agent oscillates.

Abstract: The present invention is directed to a microsphere for the controlled release of a biologically active molecule which comprises a biologically active molecule and an ester of hyaluronic acid or mixtures of said esters of hyaluronic acids, and wherein said biologically active molecule is surrounded by or adhered to said ester of hyaluronic acid, and wherein said microsphere has a diameter of between 1 .mu.m to 100 .mu.m.

Abstract: A germicidal-disinfectant detergent composition comprising (a) a cationic germicide, (b) a metal chelating agent and (c) at least one surfactant selected from anionic surfactants, nonionic surfactants and amphoteric surfactants is described. Excellent detergency and germicidal action are provided.